Shopping Cart
- Remove All
- Your shopping cart is currently empty
Amubarvimab (BRII-196), a human IgG1 monoclonal antibody (mAb), targets non-competing epitopes on the receptor binding domain (RBD) of the spike protein, exhibiting a dissociation constant (K D) of 5.88 nM. It has demonstrated efficacy in neutralizing SARS-CoV-2 variants [1] [2].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | In Stock |
Description | Amubarvimab (BRII-196), a human IgG1 monoclonal antibody (mAb), targets non-competing epitopes on the receptor binding domain (RBD) of the spike protein, exhibiting a dissociation constant (K D) of 5.88 nM. It has demonstrated efficacy in neutralizing SARS-CoV-2 variants [1] [2]. |
Cas No. | 2509447-07-6 |
Storage | store at low temperature | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.